Barry A. Polisky
Chief Executive Officer at Microbial Machines, Inc.
Profile
Barry A.
Polisky is currently the Chief Executive Officer at Microbial Machines, Inc. He is also a Professor & Chairman-Molecular Biology program at Indiana University.
Additionally, he holds positions as a Director at SanaRx Biotherapeutics, Inc. and NextRNA Therapeutics, Inc. Dr. Polisky has previously worked as the Vice President-Research at Merck & Co., Inc. from 2007 to 2008.
He was also the Chief Scientific Officer at MDRNA, Inc. from 2009 to 2010.
Prior to that, he served as the Chief Scientific Officer at Sirna Therapeutics, Inc. from 2002 to 2007.
He held the position of Vice President-Research at Thermo BioStar, Inc. from 1999 to 2002.
Dr. Polisky was the Vice President-Research & Drug Discovery at Nexstar, Inc. from 1992 to 1998.
He also worked as the Chief Scientific Officer at Adhera Therapeutics, Inc. from 2009 to 2011.
Dr. Polisky obtained his doctorate degree from The University of Colorado.
Barry A. Polisky active positions
| Companies | Position | Start |
|---|---|---|
| Indiana University | Corporate Officer/Principal | 2011-05-10 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Director/Board Member | - |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Director/Board Member | - |
| Microbial Machines, Inc. | Chief Executive Officer | - |
Former positions of Barry A. Polisky
| Companies | Position | End |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2011-09-07 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Chief Tech/Sci/R&D Officer | 2010-07-21 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 2007-12-31 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Thermo BioStar, Inc.
 Thermo BioStar, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Thermo BioStar, Inc. develops, manufactures, and markets high performance, rapid diagnostic tests. The company is based in Louisville, CO. Thermo BioStar was acquired by Alere, Inc. from Thermo Electron Corp. on October 03, 2005 for $52.50 million. | Corporate Officer/Principal | 2001-12-31 |
Training of Barry A. Polisky
| The University of Colorado | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
Thermo BioStar, Inc.
Thermo BioStar, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Thermo BioStar, Inc. develops, manufactures, and markets high performance, rapid diagnostic tests. The company is based in Louisville, CO. Thermo BioStar was acquired by Alere, Inc. from Thermo Electron Corp. on October 03, 2005 for $52.50 million. | Health Technology |
Nexstar, Inc.
 Nexstar, Inc. Miscellaneous Commercial ServicesCommercial Services Nexstar, Inc. operates as a business networking organization. It delivers comprehensive business training, systems, and coaching to independent home service plumbing, heating, air conditioning, and electrical professionals. The company was founded by Frank J. Blau Jr. in November 1992 and is headquartered in St. Paul, MN. | Commercial Services |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Health Technology |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
| Microbial Machines, Inc. |
- Stock Market
- Insiders
- Barry A. Polisky
